Skip to main content

IB Acquisition Corp.

IBAC
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001998781

No open-market purchases or sales by IB Acquisition Corp. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $1.03M in total; no superinvestor holds it.

Other share classesIBACR

Q2 2025 vs. Q1 2025

How the institutions holding IB Acquisition Corp. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of IBAC: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders40237−1
Shares11.2M295.8K11.2M+333.9K (+3.1%)
Value$115.4M$3.05M$117.4M+$5.08M (+4.5%)

2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held IB Acquisition Corp. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to IBAC in Q2 2025
InstitutionSharesValue% of portfolio
Mizuho Securities USA LLC111,915$1.16M0.02%
Jane Street Group, LLC12,868$135.0K0.00%
Citadel Advisors LLC10,072$105.5K0.00%

Sold out (4)

Institutions that held IB Acquisition Corp. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of IBAC in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Centiva Capital, LP250,000$2.58M
Highbridge Capital Management LLC198,267$2.04M
Virtu Financial LLC14,178$146.0K
Advisor Group Holdings, Inc.300$3.09K

Not filed for Q2 2025 yet (2)

Institutions that held IB Acquisition Corp. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IBAC in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Schechter Investment Advisors, LLC283,579$2.92M
Mizuho Securities USA LLC12,242$126.1K